- Home
- AXSM vs FROG Comparison
AXSM vs FROG Comparison
Compare AXSM & FROG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- FROG
- Stock Information
- Founded
- AXSM 2012
- FROG 2008
- Country
- AXSM United States
- FROG United States
- Employees
- AXSM N/A
- FROG N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- FROG Computer Software: Prepackaged Software
- Sector
- AXSM Health Care
- FROG Technology
- Exchange
- AXSM Nasdaq
- FROG Nasdaq
- Market Cap
- AXSM 4.4B
- FROG 3.6B
- IPO Year
- AXSM 2015
- FROG 2020
- Fundamental
- Price
- AXSM $98.19
- FROG $31.94
- Analyst Decision
- AXSM Strong Buy
- FROG Strong Buy
- Analyst Count
- AXSM 14
- FROG 18
- Target Price
- AXSM $124.93
- FROG $36.29
- AVG Volume (30 Days)
- AXSM 536.9K
- FROG 983.1K
- Earning Date
- AXSM 11-12-2024
- FROG 11-07-2024
- Dividend Yield
- AXSM N/A
- FROG N/A
- EPS Growth
- AXSM N/A
- FROG N/A
- EPS
- AXSM N/A
- FROG N/A
- Revenue
- AXSM $338,457,000.00
- FROG $409,670,000.00
- Revenue This Year
- AXSM $40.67
- FROG $23.68
- Revenue Next Year
- AXSM $69.27
- FROG $17.92
- P/E Ratio
- AXSM N/A
- FROG N/A
- Revenue Growth
- AXSM 51.47
- FROG 24.45
- 52 Week Low
- AXSM $60.28
- FROG $22.91
- 52 Week High
- AXSM $105.00
- FROG $48.81
- Technical
- Relative Strength Index (RSI)
- AXSM 61.45
- FROG 59.02
- Support Level
- AXSM $90.86
- FROG $29.54
- Resistance Level
- AXSM $105.00
- FROG $31.86
- Average True Range (ATR)
- AXSM 4.06
- FROG 1.17
- MACD
- AXSM 0.44
- FROG -0.02
- Stochastic Oscillator
- AXSM 64.04
- FROG 67.91
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About FROG JFrog Ltd.
JFrog Ltd provides an end-to-end, hybrid, universal DevOps Platform that powers and controls the software supply chain, enabling organizations to continuously and securely deliver software updates across any system. Its product portfolio includes JFrog Artifactory; JFrog Pipelines; JFrog Xray; JFrog Distribution; JFrog Artifactory Edge; JFrog Mission Control and JFrog Insight. Geographically, it derives a majority of revenue from Israel and also has its presence in United States, India and other regions.